Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$712M |
| 2 |
PepsiCo
PEP
|
+$669M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$635M |
| 4 |
Walmart Inc
WMT
|
+$544M |
| 5 |
Palantir
PLTR
|
+$538M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.34B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.65B |
| 3 |
Tesla
TSLA
|
+$1.45B |
| 4 |
Invesco QQQ Trust
QQQ
|
+$1.01B |
| 5 |
Apple
AAPL
|
+$833M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.48% |
| 2 | Financials | 7.27% |
| 3 | Consumer Discretionary | 6.82% |
| 4 | Communication Services | 5.06% |
| 5 | Healthcare | 4.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2451
Amneal Pharmaceuticals
AMRX
$6.02B
| $3.45M | ﹤0.01% |
344,599
-66,932
| -16% | -$601K |
|
|
GOOS
2452
PUT
Canada Goose Holdings
GOOS
$856M
| $3.45M | ﹤0.01% |
+250,000
| New | +$3.24M |
|
2453
PUT
Thermo Fisher Scientific
TMO
$213B
| $3.44M | ﹤0.01% |
7,100
-300
| -4% | -$140K |
|
2454
Diodes
DIOD
$3.77B
| $3.44M | ﹤0.01% |
64,651
-23,089
| -26% | -$1.24M |
|
2455
ODDITY Tech
ODD
$702M
| $3.43M | ﹤0.01% |
55,132
+47,716
| +643% | +$3.1M |
|
2456
Worthington Enterprises
WOR
$2.78B
| $3.43M | ﹤0.01% |
61,803
-196,715
| -76% | -$12.4M |
|
2457
Kosmos Energy
KOS
$1.5B
| $3.42M | ﹤0.01% |
2,061,912
-389,017
| -16% | -$728K |
|
2458
First Merchants
FRME
$2.71B
| $3.42M | ﹤0.01% |
90,778
-40,638
| -31% | -$1.62M |
|
2459
Sable Offshore Corp
SOC
$924M
| $3.42M | ﹤0.01% |
195,866
+65,058
| +50% | +$1.67M |
|
2460
Banc of California
BANC
$3.05B
| $3.42M | ﹤0.01% |
206,393
-205,548
| -50% | -$3.22M |
|
2461
Teekay Tankers
TNK
$2.79B
| $3.4M | ﹤0.01% |
67,294
-4,613
| -6% | -$219K |
|
2462
Zymeworks
ZYME
$1.6B
| $3.4M | ﹤0.01% |
199,023
+76,203
| +62% | +$1.09M |
|
|
DCH
2463
Dauch Corp
DCH
$1.38B
| $3.39M | ﹤0.01% |
564,745
+132,842
| +31% | +$711K |
|
2464
iShares TIPS Bond ETF
TIP
$14.5B
| $3.39M | ﹤0.01% |
30,514
+4,000
| +15% | +$442K |
|
|
DVAX
2465
DELISTED
Dynavax Technologies
DVAX
| $3.39M | ﹤0.01% |
341,689
-92,982
| -21% | -$968K |
|
2466
Stewart Information Services
STC
$2.1B
| $3.39M | ﹤0.01% |
46,218
-13,887
| -23% | -$955K |
|
|
SLNO
2467
CALL
DELISTED
Soleno Therapeutics
SLNO
| $3.38M | ﹤0.01% |
+50,000
| New | +$3.71M |
|
2468
Monarch Casino & Resort
MCRI
$2.24B
| $3.37M | ﹤0.01% |
31,837
-7,465
| -19% | -$749K |
|
2469
CALL
Goodyear
GT
$2.02B
| $3.37M | ﹤0.01% |
+450,000
| New | +$4.23M |
|
2470
PagSeguro Digital
PAGS
$2.68B
| $3.36M | ﹤0.01% |
335,824
-2,363
| -0.7% | -$21.3K |
|
2471
National Vision
EYE
$1.8B
| $3.35M | ﹤0.01% |
114,913
-31,167
| -21% | -$766K |
|
2472
ADT
ADT
$5.76B
| $3.35M | ﹤0.01% |
385,079
-85,172
| -18% | -$731K |
|
|
TWO
2473
Two Harbors Investment
TWO
$1.27B
| $3.34M | ﹤0.01% |
338,644
+138,357
| +69% | +$1.39M |
|
2474
Kura Oncology
KURA
$816M
| $3.34M | ﹤0.01% |
376,879
-26,362
| -7% | -$188K |
|
2475
Redwire
RDW
$2.3B
| $3.33M | ﹤0.01% |
370,837
-12,452
| -3% | -$146K |
|
Similar funds
Barclays's Q3 2025 Portfolio in Review
As of Q3 2025, Barclays held 5,800 positions worth $461B, up 5.7% from $436B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays's Q3 2025 filing shows 615 new, 1,596 increased, 2,751 reduced and 340 closed positions. Its largest new stake was Paramount Skydance Corp: 13,646,704 shares worth $258M. The largest sale was NVIDIA, an estimated $2.34B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Barclays's largest Q3 2025 buy was Paramount Skydance Corp: 13,646,704 shares worth $258M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q3 2025, an estimated $712M increase.
- Barclays's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $2.34B.
- Barclays fully exited Blueprint Medicines in Q3 2025, selling an estimated $200M.
- Barclays's ten largest holdings make up 40% of its $461B portfolio in Q3 2025.
- Barclays opened 615 new positions and closed 340 in Q3 2025.
- Barclays's portfolio value rose 5.7% quarter-over-quarter to $461B.
Based on Barclays's 13F filing for Q3 2025, filed 12 Nov 2025.